Accidental exposure to product: FDA reporting patterns
98,588 FDA FAERS reports mention Accidental exposure to product. 8,724 reports have a serious outcome flag.
Medicines named as suspect
- Evolocumab: 16,755 reports
- Dupilumab: 15,801 reports
- Erenumab: 10,196 reports
- Etanercept: 6,393 reports
- Pegfilgrastim: 5,045 reports
- Guselkumab: 3,513 reports
- Secukinumab: 2,763 reports
- Golimumab: 1,714 reports
- Mepolizumab: 1,702 reports
- Insulin Glargine: 1,508 reports
- Fremanezumab: 1,445 reports
- Ustekinumab: 1,441 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.